Bristol-Myers Squibb is a large pharmaceutical company that develops and sells prescription drugs, primarily for cancer, cardiovascular disease, and immune disorders. Its biggest commercial focus is immuno-oncology — drugs that use the immune system to fight cancer — with key products including Opdivo and Yervoy. Customers are hospitals, oncologists, and other specialists; revenue comes from drug sales to these providers and through insurers/payers. Roughly 70% of sales come from the US market.
Employees32,500IPOJun 23, 1952SIC2834HQRoute 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543
to
Financials
Profitability
Metric
Current
Margins
Gross Margin
70.2%
Operating Margin
28.1%
EBITDA Margin
34.2%
Net Margin
18.9%
OCF Margin
26.0%
FCF Margin
23.3%
Returns on Capital
ROE
47.9%
ROA
10.2%
ROIC
14.1%
ROCE
20.1%
ROC (Greenblatt)
150.9%
3Y ROIIC
−35.3%
Consistency
Years Profitable / 10Y
8
Valuation
Metric
Current
Earnings Multiples
P/E (TTM)
13.16
Forward P/E
8.73
P/E ex-NRI
9.17
Shiller P/E (CAPE)
34.14
Cash Flow Multiples
P/FCF
10.67
P/OCF
9.58
P/Owner Earnings
14.29
FCF Yield
9.37%
Enterprise Value Multiples
EV / EBIT
11.41
EV / Forward EBIT
9.10
EV / EBITDA
9.25
EV / Forward EBITDA
8.24
EV / Revenue
3.16
EV / Forward Revenue
3.14
Asset / Sales
P/S
2.46
P/B
5.47
P/Tangible Book
—
Growth-Adjusted
PEG
3.28
Capital Returns
Metric
Current
Dividends
Dividend Yield (TTM)
4.23%
Forward Dividend Yield
4.25%
3Y Dividend Growth
4.4%
Payout Ratio
0.39
5Y Yield on Cost
5.37%
Buybacks & Dilution
3Y Buyback Ratio
0.60%
5Y Share Change
−9.7%
Combined
Shareholder Yield
7.19%
Balance Sheet
Metric
Current
Leverage
Debt / Equity
2.02
Gross Debt / EBITDA
2.68
Cash / Debt
0.25
Equity / Assets
0.26
Coverage
Interest Coverage
8.00
Short-Term Liquidity
Current Ratio
1.53
Quick Ratio
1.38
Cash Ratio
0.59
Composite Scores
Piotroski F-Score
7
Altman Z-Score
2.75
Split History
Date
Split
1999-03-01
2:1
1997-03-03
2:1
1987-06-10
2:1
1983-05-27
2:1
1977-05-31
2:1
Ex-date
Amount
Pay date
2026-07-02
$0.63
2026-08-03
2026-04-02
$0.63
2026-05-01
2026-01-02
$0.63
2026-02-02
2025-10-03
$0.62
2025-11-03
2025-07-03
$0.62
2025-08-01
2025-04-04
$0.62
2025-05-01
2025-01-03
$0.62
2025-02-03
2024-10-04
$0.6
2024-11-01
2024-07-05
$0.6
2024-08-01
2024-04-04
$0.6
2024-05-01
10 of 163
View allDate
Transcript
Type
2026-07-30
Q2 2026 Bristol-Myers Squibb Co Earnings Call Transcript
Earnings Call
2026-06-09
Bristol-Myers Squibb Co at Goldman Sachs Healthcare Conference Transcript
Conference Presentations
2026-05-14
Bristol-Myers Squibb Co at Bank of America Global Healthcare Conference Transcript
Conference Presentations
2026-04-30
Q1 2026 Bristol-Myers Squibb Co Earnings Call Transcript
Earnings Call
2026-03-02
Bristol-Myers Squibb Co at TD Cowen Healthcare Conference Transcript
Conference Presentations
2026-02-05
Q4 2025 Bristol-Myers Squibb Co Earnings Call Transcript
Earnings Call
2026-01-12
Bristol-Myers Squibb Co at JPMorgan Healthcare Conference Transcript
Conference Presentations
2025-12-11
Bristol-Myers Squibb Co Virtual Investor Presentation on Hematology Programs Transcript
Analyst/Investor Call
2025-12-04
Bristol-Myers Squibb Co at Citi Global Healthcare Conference Transcript
Conference Presentations
2025-10-30
Q3 2025 Bristol-Myers Squibb Co Earnings Call Transcript
Earnings Call
10 of 108
5-Step DuPont Analysis
ROE %
46.70%
×
×
Net Margin %
18.87%
×
×
Operating Margin %
28.14%
Operating Income
$13.84B
÷
Revenue
$49.19B
×
Tax Burden
0.7793
Net Income
$9.28B
÷
Pretax Income
$11.91B
×
Interest Burden
0.8604
Pretax Income
$11.91B
÷
Operating Income
$13.84B
×
Asset Turnover
0.54
÷
Revenue
$49.19B
÷
Average Total Assets
$91.16B
Begin Total Assets
$94.68B
End Total Assets
$87.63B
×
Equity Multiplier
4.59
÷
Avg Total Assets
$91.16B
÷
Avg Stockholders Equity
$19.88B
Begin Equity
$17.43B
End Equity
$22.32B
Top institutional holders
Q2 2026| Holder | Shares | % Owned | Chg. shares | |
|---|---|---|---|---|
| BlackRock, Inc. | 180.4M | 8.86% | +8.7M | $10.39B |
| VANGUARD CAPITAL MANAGEMENT LLC | 133.3M | 6.55% | +1.0M | $7.68B |
| STATE STREET CORP | 102.4M | 5.03% | +3.8M | $5.90B |
| JPMORGAN CHASE & CO | 71.7M | 3.52% | -20.8M | $4.20B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 67.6M | 3.32% | +6.5M | $3.89B |
| GEODE CAPITAL MANAGEMENT, LLC | 56.4M | 2.77% | +1.2M | $3.24B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 46.9M | 2.30% | +642.9K | $2.70B |
| NORGES BANK | 36.9M | 1.81% | new | $2.12B |
| BANK OF AMERICA CORP /DE/ | 34.0M | 1.67% | +1.5M | $1.96B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31.7M | 1.56% | +21.5M | — |
10 of 2,547
View allTop insider holdings
as reported| Insider | Shares held | % Owned | |
|---|---|---|---|
| Elkins David VOfficer | 159.2K | 0.0078% | $9.52M |
| BOERNER CHRISTOPHER S.Officer | 146.9K | 0.0072% | $8.78M |
| Hirawat SamitOfficer | 83.5K | 0.0041% | $4.99M |
| Haller Julia ADirector | 34.1K | 0.0017% | $2.04M |
| Meyers Gregory ScottOfficer | 30.4K | 0.0015% | $1.81M |
| Shanahan KarinOfficer | 25.9K | 0.0013% | $1.55M |
| Plenge Robert MOfficer | 21.5K | 0.0011% | $1.29M |
| Lenkowsky AdamOfficer | 19.7K | 0.0010% | $1.18M |
| Massacesi CristianOfficer | 18.7K | 0.0009% | $1.12M |
| LEUNG SANDRAOfficer | — | — | — |
10 of 16· 1 withheld
View allRecent insider activity
through Oct 2, 2026| Insider | Action | Shares | Date | |
|---|---|---|---|---|
| Gallman CariOfficer | Option Exercise (Rule 16b-3 Exempt) | +4.6K | $0 | Oct 2, 2026 |
| Gallman CariOfficer | Tax Withholding | -2.3K | $142.6K | Oct 2, 2026 |
| Massacesi CristianOfficer | Open-Market or Private Sale | -6.2K | $403.5K | Sep 9, 2026 |
| Short Bartie WendyOfficer | Option Exercise (Rule 16b-3 Exempt) | +1.2K | $82.7K | Sep 1, 2026 |
| Short Bartie WendyOfficer | Tax Withholding | -633 | $42.4K | Sep 1, 2026 |
| Holzer Phil MOfficer | Open-Market or Private Sale | -500 | $33.8K | Aug 25, 2026 |
| Massacesi CristianOfficer | Option Exercise (Rule 16b-3 Exempt) | +51.2K | $0 | Aug 1, 2026 |
| Massacesi CristianOfficer | Tax Withholding | -26.2K | $1.71M | Aug 1, 2026 |
| Gallman CariOfficer | Option Exercise (Rule 16b-3 Exempt) | +1.1K | $0 | Aug 1, 2026 |
| Gallman CariOfficer | Tax Withholding | -543 | $35.5K | Aug 1, 2026 |
10 of 3,724
View all